Form 4 for DNTH Dianthus Therapeutics, Inc. /DE/
Accepted 2023-09-25 00:00:00 ET · period of report 2023-09-21 · accession 0000950170-23-049695 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-09-25 | 2023-09-21+ | DNTH | Randhawa Simrat | Chief Medical Off | P - Purchase | $13.20 | +4,000 | 4,000 | New | +$52.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-21 | P | A | 2,000 | $13.20 | 2,000 | D | — | — | |
| 2 | Common | Common Stock | 2023-09-22 | P | A | 2,000 | $13.20 | 4,000 | D | — | — |